BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,734 | -3.7% | 72,648 | +16.6% | 0.01% | -50.0% |
| Q2 2023 | $2,840 | -13.9% | 62,327 | -23.3% | 0.01% | -17.6% |
| Q1 2023 | $3,297 | -20.6% | 81,282 | -0.3% | 0.02% | -26.1% |
| Q4 2022 | $4,155 | -99.9% | 81,511 | -0.2% | 0.02% | -8.0% |
| Q3 2022 | $4,401,000 | -16.2% | 81,708 | -0.0% | 0.02% | -13.8% |
| Q2 2022 | $5,250,000 | -17.5% | 81,741 | -0.4% | 0.03% | 0.0% |
| Q1 2022 | $6,362,000 | -16.4% | 82,045 | -7.4% | 0.03% | -6.5% |
| Q4 2021 | $7,606,000 | +5.3% | 88,602 | -1.4% | 0.03% | -3.1% |
| Q3 2021 | $7,224,000 | -0.4% | 89,818 | -0.3% | 0.03% | 0.0% |
| Q2 2021 | $7,251,000 | -5.1% | 90,071 | -0.5% | 0.03% | -11.1% |
| Q1 2021 | $7,637,000 | +4.7% | 90,546 | -0.4% | 0.04% | +2.9% |
| Q4 2020 | $7,296,000 | -2.3% | 90,921 | -2.0% | 0.04% | -12.5% |
| Q3 2020 | $7,464,000 | -6.9% | 92,810 | -0.3% | 0.04% | -13.0% |
| Q2 2020 | $8,015,000 | +7.2% | 93,085 | +1.0% | 0.05% | -11.5% |
| Q1 2020 | $7,480,000 | +0.8% | 92,130 | +3.8% | 0.05% | +23.8% |
| Q4 2019 | $7,420,000 | -4.4% | 88,729 | +0.0% | 0.04% | -10.6% |
| Q3 2019 | $7,760,000 | +6.4% | 88,715 | -0.4% | 0.05% | +4.4% |
| Q2 2019 | $7,292,000 | -2.2% | 89,040 | -2.9% | 0.04% | -6.2% |
| Q1 2019 | $7,458,000 | +30.0% | 91,723 | +5.2% | 0.05% | +17.1% |
| Q4 2018 | $5,738,000 | -14.8% | 87,172 | -0.2% | 0.04% | 0.0% |
| Q3 2018 | $6,736,000 | +4.3% | 87,383 | -0.1% | 0.04% | -2.4% |
| Q2 2018 | $6,459,000 | +13.1% | 87,477 | -0.4% | 0.04% | +10.5% |
| Q1 2018 | $5,711,000 | -2.3% | 87,815 | -2.9% | 0.04% | +2.7% |
| Q4 2017 | $5,847,000 | +6.8% | 90,458 | +3.6% | 0.04% | -5.1% |
| Q3 2017 | $5,477,000 | -2.5% | 87,279 | -6.0% | 0.04% | -4.9% |
| Q2 2017 | $5,619,000 | +16.6% | 92,820 | -0.2% | 0.04% | +10.8% |
| Q1 2017 | $4,821,000 | +13.8% | 92,963 | -2.7% | 0.04% | +8.8% |
| Q4 2016 | $4,237,000 | -12.6% | 95,560 | -6.2% | 0.03% | -12.8% |
| Q3 2016 | $4,850,000 | +1.4% | 101,893 | -3.6% | 0.04% | -2.5% |
| Q2 2016 | $4,781,000 | -2.6% | 105,722 | -11.5% | 0.04% | 0.0% |
| Q1 2016 | $4,908,000 | -58.6% | 119,485 | -61.5% | 0.04% | -60.0% |
| Q4 2015 | $11,850,000 | +15.9% | 310,621 | -0.2% | 0.10% | +11.1% |
| Q3 2015 | $10,228,000 | -70.2% | 311,346 | -36.5% | 0.09% | -68.0% |
| Q2 2015 | $34,287,000 | +58.4% | 490,303 | +55.1% | 0.28% | +57.9% |
| Q1 2015 | $21,649,000 | -7.7% | 316,050 | -1.3% | 0.18% | -8.2% |
| Q4 2014 | $23,458,000 | +1.9% | 320,077 | -0.2% | 0.19% | -1.5% |
| Q3 2014 | $23,022,000 | -1.5% | 320,773 | -0.8% | 0.20% | 0.0% |
| Q2 2014 | $23,380,000 | -3.7% | 323,372 | -2.0% | 0.20% | -5.3% |
| Q1 2014 | $24,274,000 | -21.5% | 329,893 | -25.8% | 0.21% | -21.8% |
| Q4 2013 | $30,929,000 | +4.6% | 444,707 | -1.2% | 0.27% | -2.6% |
| Q3 2013 | $29,568,000 | -7.9% | 450,107 | -2.9% | 0.27% | -9.9% |
| Q2 2013 | $32,111,000 | – | 463,559 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |